VIVUS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Dec 2025)
What this means for you
Registered since 01 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87954646
- Registration number
- 5875253
- Mark type
- Stylized text
- Filed
- 08 Jun 2018
- Published for opposition
- 14 May 2019
- Registered
- 01 Oct 2019
- Attorney of record
- Matthew J. Snider
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of the exocrine system, and exocrine deficiencies, disorders and diseases; pharmaceutical preparations for the treatment of the digestive system; pharmaceutical preparations for the treatment of pancreatic diseases and disorders, enzyme disorders and deficiencies, and gastrointestinal diseases and disorders
Owner
- VIVUS LLC, CAMPBELL, CA, US
- Vivus, Inc., Campbell, CA, US
- Vivus, Inc., Campbell, CA, US
- Vivus, Inc., Campbell, CA, US
Prior registrations
Prosecution history
- 12 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 01 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Oct 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Aug 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Aug 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jul 2019 — USE AMENDMENT FILED
- 22 Aug 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jul 2019 — TEAS STATEMENT OF USE RECEIVED
- 09 Jul 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED